Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis

AbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underly...

Full description

Bibliographic Details
Main Authors: Ying Feng, Han Dong, Liyan Zheng
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883
_version_ 1797234835354288128
author Ying Feng
Han Dong
Liyan Zheng
author_facet Ying Feng
Han Dong
Liyan Zheng
author_sort Ying Feng
collection DOAJ
description AbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underlying regulatory mechanisms.Materials and methods Human endometrial stromal cells (HESCs) were isolated from patients with EMs or control subjects. HESCs were treated with 25, 50, 100, or 200 μM ligustrazine for 1, 3, 6, or 12 h. Western blot and enzyme-linked immunosorbent assays were performed to determine the levels of proteins and inflammatory cytokines, respectively. The binding between STAT3 and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was assessed by chromatin immunoprecipitation and dual-luciferase reporter assays. The relationship between IGF2BP1 and RELA was assessed by RNA immunoprecipitation and RNA pull-down assay.Results Phosphorylated STAT3, IGF2BP1, RELA, TNF-α, IL-6, and IL-1β were upregulated in EMs tissues compared with control tissues (by 1.79-, 2.55-, 1.58-, 3.01-, 2.55-, and 3.34-fold, respectively). Ligustrazine inhibited the expression of p-STAT3, IGF2BP1, RELA, IL-6, TNF-α, and IL-1β. Overexpression of STAT3 promoted RELA-mediated inflammatory responses, while ligustrazine (100 µM) notably reversed this phenomenon. Ligustrazine also alleviated RELA-induced inflammation via downregulating IGF2BP1. STAT3 bound to the promoter of IGF2BP1, and IGF2BP1 bound to the RELA mRNA.Discussion and conclusion Ligustrazine inhibited inflammation in EMs via regulating the STAT3/IGF2BP1/RELA axis. These findings propose a new agent against EMs and support the development of ligustrazine-based treatment strategies for EMs.
first_indexed 2024-03-09T00:09:14Z
format Article
id doaj.art-6fb2b2cd94d84dd8bc5744fe99e2a727
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-24T16:38:23Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-6fb2b2cd94d84dd8bc5744fe99e2a7272024-03-29T11:10:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162023-12-0161166667310.1080/13880209.2023.2195883Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axisYing Feng0Han Dong1Liyan Zheng2The Second Affiliated Hospital of Nanchang University, Nanchang, P.R. ChinaDepartment of Obstetrics and Gynecology, Gynecology Women and Children’s Hospital of Jinzhou, Jinzhou, P.R. ChinaDepartment of Obstetrics and Gynecology, ShangRao Guangxin District Traditional Chinese Medicine Hospital, Shangrao, P.R. ChinaAbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underlying regulatory mechanisms.Materials and methods Human endometrial stromal cells (HESCs) were isolated from patients with EMs or control subjects. HESCs were treated with 25, 50, 100, or 200 μM ligustrazine for 1, 3, 6, or 12 h. Western blot and enzyme-linked immunosorbent assays were performed to determine the levels of proteins and inflammatory cytokines, respectively. The binding between STAT3 and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was assessed by chromatin immunoprecipitation and dual-luciferase reporter assays. The relationship between IGF2BP1 and RELA was assessed by RNA immunoprecipitation and RNA pull-down assay.Results Phosphorylated STAT3, IGF2BP1, RELA, TNF-α, IL-6, and IL-1β were upregulated in EMs tissues compared with control tissues (by 1.79-, 2.55-, 1.58-, 3.01-, 2.55-, and 3.34-fold, respectively). Ligustrazine inhibited the expression of p-STAT3, IGF2BP1, RELA, IL-6, TNF-α, and IL-1β. Overexpression of STAT3 promoted RELA-mediated inflammatory responses, while ligustrazine (100 µM) notably reversed this phenomenon. Ligustrazine also alleviated RELA-induced inflammation via downregulating IGF2BP1. STAT3 bound to the promoter of IGF2BP1, and IGF2BP1 bound to the RELA mRNA.Discussion and conclusion Ligustrazine inhibited inflammation in EMs via regulating the STAT3/IGF2BP1/RELA axis. These findings propose a new agent against EMs and support the development of ligustrazine-based treatment strategies for EMs.https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883Endometriosisinflammationtumor necrosis factor-αinterleukin-1βinterleukin-6
spellingShingle Ying Feng
Han Dong
Liyan Zheng
Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
Pharmaceutical Biology
Endometriosis
inflammation
tumor necrosis factor-α
interleukin-1β
interleukin-6
title Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
title_full Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
title_fullStr Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
title_full_unstemmed Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
title_short Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
title_sort ligustrazine inhibits inflammatory response of human endometrial stromal cells through the stat3 igf2bp1 rela axis
topic Endometriosis
inflammation
tumor necrosis factor-α
interleukin-1β
interleukin-6
url https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883
work_keys_str_mv AT yingfeng ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis
AT handong ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis
AT liyanzheng ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis